TNF and anemia: Song et al. [18] reported that in RA patients with anemia, treatment with both tocilizumab and TNF inhibitors (etanercept, infliximab, or adalimumab) resulted in significant improvements in anemia and disease activity, while the effect was more pronounced in patients treated with tocilizumab vs. those treated with TNF inhibitors.